Cargando…
Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets
Human embryonic stem cells (hESCs) provide opportunities for cell replacement therapy of insulin-dependent diabetes. Therapeutic quantities of human stem cell-derived islets (SC-islets) can be produced by directed differentiation. However, preventing allo-rejection and recurring autoimmunity, withou...
Autores principales: | Sintov, Elad, Nikolskiy, Igor, Barrera, Victor, Hyoje-Ryu Kenty, Jennifer, Atkin, Alexander S., Gerace, Dario, Ho Sui, Shannan J., Boulanger, Kyle, Melton, Douglas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481918/ https://www.ncbi.nlm.nih.gov/pubmed/36055241 http://dx.doi.org/10.1016/j.stemcr.2022.08.002 |
Ejemplares similares
-
Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance
por: Gerace, Dario, et al.
Publicado: (2023) -
Retrieval and purification of human β cells from stem cell-derived islet engrafted mice
por: Kenty, Jennifer Hyoje-Ryu, et al.
Publicado: (2021) -
Testing Pancreatic Islet Function at the Single Cell Level by Calcium Influx with Associated Marker Expression
por: Kenty, Jennifer H. R., et al.
Publicado: (2015) -
NKT cells reject islets
por: Van Epps, Heather L.
Publicado: (2005) -
Genetic manipulation of stress pathways can protect stem-cell-derived islets from apoptosis in vitro
por: Leite, Nayara C., et al.
Publicado: (2022)